These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 12030393

  • 1. Post-antifungal effect and effects of sub-MIC concentrations on previously treated Candida spp.: influence of exposure time and concentration.
    García MT, Llorente MT, Mínguez F, Prieto J.
    Scand J Infect Dis; 2002; 34(3):197-200. PubMed ID: 12030393
    [Abstract] [Full Text] [Related]

  • 2. Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
    García MT, Llorente MT, Mínguez F, Prieto J.
    Scand J Infect Dis; 2000; 32(6):669-73. PubMed ID: 11200379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Ellepola AN, Samaranayake LP.
    Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
    Zhanel GG, Saunders DG, Hoban DJ, Karlowsky JA.
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
    [Abstract] [Full Text] [Related]

  • 12. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI, Ghezzi MC, Cipriani P, Mancini C, Trancassini M.
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [Abstract] [Full Text] [Related]

  • 13. Activity of voriconazole: post-antifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes.
    García MT, Llorente MT, Lima JE, Mínguez F, Del Moral F, Prieto J.
    Scand J Infect Dis; 1999 Jun; 31(5):501-4. PubMed ID: 10576131
    [Abstract] [Full Text] [Related]

  • 14. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
    Silva V, Alvarado D, Diaz MC.
    Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the Post-Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata.
    Carvalhaes CG, Rhomberg PR, Pfaller MA, Locke JB, Castanheira M.
    Mycoses; 2022 Nov; 65(11):1040-1044. PubMed ID: 35778886
    [Abstract] [Full Text] [Related]

  • 18. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A, Sancak B, Arikan S.
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E, Parras P, Lozano MC.
    Chemotherapy; 1992 Apr; 38(5):335-9. PubMed ID: 1337508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.